An established European pharma company needed an opportunity assessment for a reformulation of a marketed biologic.
We quantified the market opportunity and assessed the market positioning and unique selling propositions (USPs) of the target product. We also reviewed the competitive environment, assessing sales and pricing of competitor products (based on IMS data) and likely competitive responses from established players in the market.